Cargando…

TCTAP A-071 Comparison of Perindopril vs. Losartan With Regard to Pro-Coagulation Factors in Adipocytes Exposed to Sars-Cov-2 Spike Protein

Detalles Bibliográficos
Autores principales: Hermawan, Hanestya Oky, Harsoyo, Primasitha Maharany, Al-Farabi, Makhyan Jibril, Rurus Suryawan, I Gde, Ardiana, Meity
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119551/
http://dx.doi.org/10.1016/j.jacc.2023.03.096
_version_ 1785029044759166976
author Hermawan, Hanestya Oky
Harsoyo, Primasitha Maharany
Al-Farabi, Makhyan Jibril
Rurus Suryawan, I Gde
Ardiana, Meity
author_facet Hermawan, Hanestya Oky
Harsoyo, Primasitha Maharany
Al-Farabi, Makhyan Jibril
Rurus Suryawan, I Gde
Ardiana, Meity
author_sort Hermawan, Hanestya Oky
collection PubMed
description
format Online
Article
Text
id pubmed-10119551
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-101195512023-04-21 TCTAP A-071 Comparison of Perindopril vs. Losartan With Regard to Pro-Coagulation Factors in Adipocytes Exposed to Sars-Cov-2 Spike Protein Hermawan, Hanestya Oky Harsoyo, Primasitha Maharany Al-Farabi, Makhyan Jibril Rurus Suryawan, I Gde Ardiana, Meity J Am Coll Cardiol Article Published by Elsevier Inc. 2023-04-25 2023-04-21 /pmc/articles/PMC10119551/ http://dx.doi.org/10.1016/j.jacc.2023.03.096 Text en Copyright © 2023 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Hermawan, Hanestya Oky
Harsoyo, Primasitha Maharany
Al-Farabi, Makhyan Jibril
Rurus Suryawan, I Gde
Ardiana, Meity
TCTAP A-071 Comparison of Perindopril vs. Losartan With Regard to Pro-Coagulation Factors in Adipocytes Exposed to Sars-Cov-2 Spike Protein
title TCTAP A-071 Comparison of Perindopril vs. Losartan With Regard to Pro-Coagulation Factors in Adipocytes Exposed to Sars-Cov-2 Spike Protein
title_full TCTAP A-071 Comparison of Perindopril vs. Losartan With Regard to Pro-Coagulation Factors in Adipocytes Exposed to Sars-Cov-2 Spike Protein
title_fullStr TCTAP A-071 Comparison of Perindopril vs. Losartan With Regard to Pro-Coagulation Factors in Adipocytes Exposed to Sars-Cov-2 Spike Protein
title_full_unstemmed TCTAP A-071 Comparison of Perindopril vs. Losartan With Regard to Pro-Coagulation Factors in Adipocytes Exposed to Sars-Cov-2 Spike Protein
title_short TCTAP A-071 Comparison of Perindopril vs. Losartan With Regard to Pro-Coagulation Factors in Adipocytes Exposed to Sars-Cov-2 Spike Protein
title_sort tctap a-071 comparison of perindopril vs. losartan with regard to pro-coagulation factors in adipocytes exposed to sars-cov-2 spike protein
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119551/
http://dx.doi.org/10.1016/j.jacc.2023.03.096
work_keys_str_mv AT hermawanhanestyaoky tctapa071comparisonofperindoprilvslosartanwithregardtoprocoagulationfactorsinadipocytesexposedtosarscov2spikeprotein
AT harsoyoprimasithamaharany tctapa071comparisonofperindoprilvslosartanwithregardtoprocoagulationfactorsinadipocytesexposedtosarscov2spikeprotein
AT alfarabimakhyanjibril tctapa071comparisonofperindoprilvslosartanwithregardtoprocoagulationfactorsinadipocytesexposedtosarscov2spikeprotein
AT rurussuryawanigde tctapa071comparisonofperindoprilvslosartanwithregardtoprocoagulationfactorsinadipocytesexposedtosarscov2spikeprotein
AT ardianameity tctapa071comparisonofperindoprilvslosartanwithregardtoprocoagulationfactorsinadipocytesexposedtosarscov2spikeprotein